Chile - Lipid Modifying Medicine Use
Since 2014, Chile Lipid Modifying Medicine Use grew 1.4% year on year. With 46.9 Units (Defined Daily Dosage) Per Thousand Persons Per Day in 2019, the country was ranked number 26 among other countries in Lipid Modifying Medicine Use. Chile is overtaken by Estonia, which was ranked number 25 at 66.5 Units (Defined Daily Dosage) Per Thousand Persons Per Day and is followed by Lithuania at 39.6 Units (Defined Daily Dosage) Per Thousand Persons Per Day. Denmark lead the ranking with 159.5 Units (Defined Daily Dosage) Per Thousand Persons Per Day in 2019, that is a growth of 3.5% compared to 2018. United Kingdom, Belgium and Norway respectively ranked number 2, 3 and 4 in this ranking. Lithuania witnessed the best average annual growth at +15% per year, while Slovakia witnessed the worst performance at -7% per year.
Loading...
Date | Units (Defined Daily Dosage) Per Thousand Persons Per Day |
---|---|
2019 | 46.90 |
2018 | 46.30 |
2017 | 37.40 |
2016 | 68.70 |
2015 | 48.80 |
How does Chile rank in Lipid Modifying Medicine Use?
# | 28 Countries | Units (Defined Daily Dosage) Per Thousand Persons Per Day | Last | YoY | 5‑years CAGR | ||
---|---|---|---|---|---|---|---|
1 |
#1
Denmark
|
160 | 2019 | +3.5 % | +3.8 % | View data | |
2 |
#2
United Kingdom
|
153 | 2019 | +1.7 % | +2.3 % | View data | |
25 |
#25
Estonia
|
67 | 2019 | +2.9 % | +7.0 % | View data | |
26 |
#26
Chile
|
47 | 2019 | +1.3 % | +1.4 % | View data | |
27 |
#27
Lithuania
|
40 | 2019 | +5.6 % | +15.0 % | View data |